Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Amicus Therapeutics (FOLD)

Amicus Therapeutics (FOLD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,730,385
  • Shares Outstanding, K 264,316
  • Annual Sales, $ 260,890 K
  • Annual Income, $ -276,850 K
  • 60-Month Beta 1.17
  • Price/Sales 10.11
  • Price/Cash Flow N/A
  • Price/Book 8.47
Trade FOLD with:

Options Overview

Details
  • Implied Volatility 72.43%
  • Historical Volatility 54.24%
  • IV Percentile 51%
  • IV Rank 21.46%
  • IV High 237.40% on 02/11/21
  • IV Low 27.35% on 05/08/20
  • Put/Call Vol Ratio 2.24
  • Today's Volume 1,992
  • Volume Avg (30-Day) 1,405
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 77,180
  • Open Int (30-Day) 46,354

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.23
  • Number of Estimates 5
  • High Estimate -0.17
  • Low Estimate -0.26
  • Prior Year -0.35
  • Growth Rate Est. (year over year) +34.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.83 +12.10%
on 03/30/21
10.65 -7.06%
on 03/17/21
-0.60 (-5.73%)
since 03/16/21
3-Month
8.83 +12.10%
on 03/30/21
22.18 -55.37%
on 01/19/21
-11.94 (-54.67%)
since 01/15/21
52-Week
8.83 +12.10%
on 03/30/21
25.39 -61.02%
on 12/22/20
-0.71 (-6.71%)
since 04/16/20

Most Recent Stories

More News
Global Fabry Disease Treatment Market Size Value Surges to Record USD 3.78 Billion by 2026: Facts & Factors

Facts and Factors have published a new research report titled "Fabry Disease Treatment Market by Drugs (Agalsidase Beta, Migalastat, and Pipeline Drugs), By Treatment (Enzyme Replacement Therapy (ERT),...

FOLD : 9.92 (-3.97%)
SHPG : 179.20 (+4.10%)
Thinking about buying stock in Grupo Televisa, Phunware, Immunitybio, Flexion Therapeutics, or Amicus Therapeutics?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TV, PHUN, IBRX, FLXN, and FOLD.

FLXN : 9.30 (-3.83%)
FOLD : 9.92 (-3.97%)
IBRX : 17.05 (-1.22%)
PHUN : 1.4700 (-7.55%)
TV : 12.99 (+6.21%)
Amicus Therapeutics Announces Presentation and Posters at the 2021 MDA Clinical & Scientific Conference

Amicus Therapeutics (Nasdaq: FOLD), today announced one oral presentation and two posters highlighting its development program for Pompe disease will be included at the 2021 MDA Virtual Clinical & Scientific...

FOLD : 9.92 (-3.97%)
Shares of FOLD Down 52.5% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Amicus Therapeut (NASDAQ:FOLD) on January 5th, 2021 at $21.90. In approximately 2 months, Amicus Therapeut has returned 52.52% as of today's recent price of $10.40....

FOLD : 9.92 (-3.97%)
49.7% Return Seen to Date on SmarTrend Amicus Therapeut Call (FOLD)

SmarTrend identified a Downtrend for Amicus Therapeut (NASDAQ:FOLD) on January 5th, 2021 at $21.90. In approximately 2 months, Amicus Therapeut has returned 49.67% as of today's recent price of $11.02....

FOLD : 9.92 (-3.97%)
Amicus' (FOLD) Q4 Earnings Miss Estimates, Sales Beat on Galafold

Amicus (FOLD) reports a wider-than-expected Q4 loss but sales beat estimates.

SNY : 51.20 (+1.01%)
RHHBY : 42.1400 (+0.69%)
FOLD : 9.92 (-3.97%)
TAK : 17.04 (-0.93%)
Amicus Therapeutics (FOLD) Reports Q4 Loss, Tops Revenue Estimates

Amicus Therapeutics (FOLD) delivered earnings and revenue surprises of -12.50% and 0.10%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

FOLD : 9.92 (-3.97%)
Amicus Therapeutics Announces Full-Year 2020 Financial Results and Corporate Updates

2020 Total Galafold Revenue of $260.9M; Increased 43 Percent Year-on-Year

FOLD : 9.92 (-3.97%)
45.4% Return Seen to Date on SmarTrend Amicus Therapeut Call (FOLD)

SmarTrend identified a Downtrend for Amicus Therapeut (NASDAQ:FOLD) on January 5th, 2021 at $21.90. In approximately 2 months, Amicus Therapeut has returned 45.42% as of today's recent price of $11.95....

FOLD : 9.92 (-3.97%)
Will Amicus Therapeutics (FOLD) Report Negative Earnings Next Week? What You Should Know

Amicus Therapeutics (FOLD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FOLD : 9.92 (-3.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in...

See More

Key Turning Points

3rd Resistance Point 10.99
2nd Resistance Point 10.69
1st Resistance Point 10.51
Last Price 9.92
1st Support Level 10.03
2nd Support Level 9.73
3rd Support Level 9.55

See More

52-Week High 25.39
Fibonacci 61.8% 19.06
Fibonacci 50% 17.11
Fibonacci 38.2% 15.16
Last Price 9.92
52-Week Low 8.83

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar